Abstracts tagged "Knee and pain"

Abstract Number: 1309 • 2019 ACR/ARP Annual Meeting
Concordance of Baseline Pain Measures (Across Two Reporting Instruments) Influences Treatment Effect: Post Hoc Analysis of a Phase 3 Randomized Controlled Trial of Triamcinolone Acetonide Extended-Release in Patients with Knee Osteoarthritis
Philip G Conaghan¹, Edgar Ross ², Alan Kivitz ³, Dennis Turk ⁴, Andrew Spitzer ⁵, Deryk Jones ⁶, Ryan Lanier ⁷, Amy Cinar ⁸, Joelle Lufkin ⁸ and Scott Kelley ⁸, ¹Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds & NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom, ²Brigham and Women's Hospital, Boston, MA, ³Altoona Center for Clinical Research, Duncansville, PA, ⁴University of Washington, Seattle, ⁵Cedars-Sinai Medical Center, Los Angeles, ⁶Ochsner Sports Medicine Institute, Harahan, GA, ⁷Analgesic Solutions, Natick, ⁸Flexion Therapeutics, Burlington
Background/Purpose: In a Phase 3 randomized controlled study, differing efficacy results were observed when triamcinolone acetonide extended-release (TA-ER) was compared to conventional TA crystalline suspension…
Abstract Number: 3270 • 2015 ACR/ARHP Annual Meeting
Correction of Limb Length Inequality in Adults with Knee or Hip Symptoms: A Pilot Study
Yvonne M. Golightly¹, Michael T. Gross², Amanda Nelson³, Leigh F. Callahan⁴ and Joanne M. Jordan⁴, ¹Epidemiology, University of North Carolina, Chapel Hill, NC, ²University of North Carolina, Chapel Hill, NC, ³Division of Rheumatology, Allergy, and Immunology and Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, ⁴Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC
Background/Purpose: Limb length inequality (LLI; paired lower extremities of unequal length) is associated with knee and hip osteoarthritis (OA) and symptoms consistent with OA (pain,…
Abstract Number: 64 • 2014 ACR/ARHP Annual Meeting
Effect of Family Support on Short-and Intermediate Term Pain and Function Outcomes after Knee or Hip Replacement
Jasvinder A. Singh¹, Kenneth G. Saag², Celeste Lemay³, Jeroan Allison⁴ and Patricia D. Franklin⁵, ¹University of Alabama at Birmingham, Birmingham, AL, ²Immunology & Rheumatology, The University of Alabama at Birmingham, Birmingham, AL, ³University of Massachusetts Medical School, Worchester, MA, ⁴Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, ⁵Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA
Background/Purpose: Patients who undergo total knee replacement (TKR) and total hip replacement (THR) need significant help in the immediate post-operative period, when discharged to home.…
Abstract Number: 1078 • 2013 ACR/ARHP Annual Meeting
Trends In Prevalence Of Knee Pain Among US Adults, National Health Interview Survey 2002-2010
Jennifer M. Hootman¹, Charles G. Helmick² and Yvonne M. Golightly³, ¹Division of Population Health, Centers for Disease Control and Prevention, Kennesaw, GA, ²National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, ³Gillings School of Global Public Health, Dept of Epidemiology, Thurston Arthritis Research Center, Injury Prevention Research Center, University of North Carolina Dept of Epidemiology, Chapel Hill, NC
Background/Purpose: Aging of the population as well as the obesity epidemic will play a significant roll in future cases of arthritis and other lower extremity…
Abstract Number: 254 • 2012 ACR/ARHP Annual Meeting
Effects of Strontium Ranelate On Knee Osteoarthritis Pain: A Responder Analysis
JY. Reginster¹, Roland Chapurlat², N. Bellamy³, E. Czerwinski⁴, JP Devogelaer⁵, Lyn March⁶, K. Pavelka⁷ and Cyrus Cooper⁸, ¹Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium, ²Hôpital Edouard Herriot, Lyon, France, ³CONROD. The University of Queensland, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia, ⁴Krakow Medical Centre, Kraków, Poland, ⁵Service de Rhumatologie, Cliniques Universitaires St. Luc, Brussels, Belgium, ⁶University of Sydney, Institute of Bone and Joint Research, Royal North Shore Hospital, St Leonards - Sydney, Australia, ⁷Department of Clinical and Experimental Rheumatology, Charles University, Prague, Czech Republic, ⁸NDORMS; MRC Lifecourse Epidemiology Unit, University of Oxford; Southampton General Hospital, Southampton, United Kingdom
Background/Purpose: In a large, randomised, placebo-controlled, double-blind phase-III 3-year study (SEKOIA), strontium ranelate 2g/day (SrRan) has demonstrated structure-modifying activity associated with statistically significant symptomatic improvement…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].